Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
≥99% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Information
BI-409306 BI 409306 (SUB 166499) is a potent and selective inhibitor of human and rat PDE9A with mean IC50 of 65 nM and 168 nM, respectively. Treatment with BI 409306 increases brain cGMP levels, promotes long-term potentiation, and improves episodic and working memory performance in rodents.
Targets
human PDE9A (Cell-free assay); rat PDE9A (Cell-free assay) 65 nM; 168 nM
| ALogP | 0.421 |
|---|---|
| hba_count | 5 |
| Recuento HBD | 1 |
| Enlace rotable | 3 |
| Pubchem Sid | 488203011 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488203011 |
| Sonrisas canónicas | C1COCCC1N2C3=C(C=N2)C(=O)NC(=N3)CC4=CC=CC=N4 |
| IUPAC Name | 1-(oxan-4-yl)-6-(pyridin-2-ylmethyl)-5H-pyrazolo[3,4-d]pyrimidin-4-one |
| InChIKey | BZTIJCSHNVZMES-UHFFFAOYSA-N |
| INCHI | 1S/C16H17N5O2/c22-16-13-10-18-21(12-4-7-23-8-5-12)15(13)19-14(20-16)9-11-3-1-2-6-17-11/h1-3,6,10,12H,4-5,7-9H2,(H,19,20,22) |
| Isómeros SMILES | C1COCCC1N2C3=C(C=N2)C(=O)NC(=N3)CC4=CC=CC=N4 |
| Peso molecular | 311.34 |
| Reaxy-Rn | 19661491 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=19661491&ln= |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organoheterocyclic compounds |
| Clase | Pyrazolopyrimidines |
| Subclass | Pyrazolo[3,4-d]pyrimidines |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Pyrazolo[3,4-d]pyrimidines |
| Alternative Parents | Pyrimidones Pyridines and derivatives Oxanes Vinylogous amides Pyrazoles Heteroaromatic compounds Lactams Oxacyclic compounds Dialkyl ethers Azacyclic compounds Organopnictogen compounds Organonitrogen compounds Organic oxides Hydrocarbon derivatives |
| Molecular Framework | Aromatic heteropolycyclic compounds |
| Substituents | Pyrazolo[3,4-d]pyrimidine - Pyrimidone - Pyrimidine - Pyridine - Oxane - Heteroaromatic compound - Vinylogous amide - Pyrazole - Azole - Lactam - Oxacycle - Azacycle - Ether - Dialkyl ether - Organic nitrogen compound - Organic oxygen compound - Organopnictogen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Organonitrogen compound - Aromatic heteropolycyclic compound |
| Descripción | This compound belongs to the class of organic compounds known as pyrazolo[3,4-d]pyrimidines. These are aromatic heterocyclic compounds containing a pyrazolo[3,4-d]pyrimidine ring system, which consists of a pyrazole ring fused to but and not sharing a nitrogen atom with a pyrimidine ring. |
| External Descriptors | Not available |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Fecha | Articulo |
|---|---|---|---|
| Certificate of Analysis | Jan 19, 2026 | B412142 | |
| Certificate of Analysis | Jan 19, 2026 | B412142 | |
| Certificate of Analysis | Jan 19, 2026 | B412142 | |
| Certificate of Analysis | Jan 19, 2026 | B412142 | |
| Certificate of Analysis | Jan 19, 2026 | B412142 | |
| Certificate of Analysis | Jan 19, 2026 | B412142 | |
| Certificate of Analysis | Jan 19, 2026 | B412142 | |
| Certificate of Analysis | Jan 19, 2026 | B412142 |
| Solubilidad | Solubility (25°C) In vitro DMSO: 62 mg/mL (199.13 mM); Ethanol: 4 mg/mL (12.84 mM); Water: ˂1 mg/mL |
|---|---|
| DMSO (mg/ml) Solubilidad máxima | 62 |
| DMSO (mM) Solubilidad máxima | 199.13920472795 |
| Agua (mg/ml) Solubilidad máxima | ˂1 |
| Peso molecular | 311.340 g/mol |
| XLogP3 | 0.200 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 3 |
| Exact Mass | 311.138 Da |
| Monoisotopic Mass | 311.138 Da |
| Topological Polar Surface Area | 81.400 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 477.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |